UPDATE: Goldman Sachs Starts Actus Medical (AFIB) at Neutral
Tweet Send to a Friend
(Updated - October 22, 2021 5:58 AM EDT)
Goldman Sachs analyst Amit Hazan initiates coverage on Actus Medical (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Goldman Sachs analyst Amit Hazan initiates coverage on Actus Medical (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
